Cukrová V, Hrkal Z, Koprivová H, Neuwirt J
Blut. 1986 Jan;52(1):51-8. doi: 10.1007/BF00320142.
Conditioned media from the human myeloid leukemic cell line ML-2 contain a factor that inhibits the entry of normal CFU-GM into S phase of mitotic cycle as measured by the 3H-TdR suicide technique. This factor was detected in conditioned media prepared by incubating 5 X 10(6) ML-2 cells/ml or 1 X 10(6) ML-2 cells/ml in serum-free RPMI for 5 or 24 hours respectively, and was isolated by ultrafiltration through an XM 300 Diaflo membrane followed by chromatography on Sepharose 6 B. Ferritin, prepared from human placenta, had the same inhibitory effect on CFU-GM. Antibodies against human placental ferritin completely inactivated the inhibitory effect of both human placental ferritin and the factor released from ML-2 cells. The inhibitory activity produced by the cell-line ML-2 was considered as LIA (leukemia cell-derived inhibitory activity) earlier found in HL-60 cell line and AML and CML cells.
用人髓系白血病细胞系ML-2制备的条件培养基含有一种因子,通过3H-TdR自杀技术检测发现,该因子可抑制正常CFU-GM进入有丝分裂周期的S期。在分别于无血清RPMI中以5×10(6)个细胞/毫升或1×10(6)个细胞/毫升培养ML-2细胞5小时或24小时所制备的条件培养基中检测到了这种因子,并通过XM 300 Diaflo膜超滤,随后在Sepharose 6 B上进行层析将其分离出来。从人胎盘中制备的铁蛋白对CFU-GM具有相同的抑制作用。抗人胎盘铁蛋白抗体可完全消除人胎盘铁蛋白和ML-2细胞释放的因子的抑制作用。细胞系ML-2产生的抑制活性被认为是先前在HL-60细胞系以及急性髓系白血病和慢性髓系白血病细胞中发现的白血病细胞衍生抑制活性(LIA)。